BioPharmGuy logo
Sponsored By:
Trianni Inc.
Weekly Update Subscription
Emery Pharma
Bioenvision  is defunct.

Fate: Acquired by Genzyme, Oct 2007, $345M


------------------
If you believe any of this information is incorrect, please let us know.